Mohammad Sadegh Rezai - Infectious Diseases

Author Information

Mohammad Sadegh Rezai is a distinguished researcher affiliated with the Pediatric Infectious Diseases Research Center at the Communicable Diseases Institute, Mazandaran University of Medical Sciences, located in Sari, Iran. His expertise lies prominently in the field of infectious diseases, where he has made significant contributions through both research and clinical practice.

Research Contributions

Dr. Rezai's research spans a wide array of topics within the realm of infectious diseases. Notably, his work includes studies on the potential of lytic bacteriophages as disinfectants, the development of a national data set for Kawasaki Disease in Iran, and various analyses related to the Global Burden of Disease Study. His studies frequently address critical global health issues, such as tuberculosis, COVID-19, and childhood vaccination coverage, showcasing his commitment to enhancing public health through research.

Aliases

Dr. Mohammad Sadegh Rezai is also known by other names, including M S Rezai and Mohammad S. Rezai. These aliases are often used in academic publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	21,559
H-index	36
Paper Count	162

Publications:

Potential of lytic bacteriophages as disinfectant to control of Pseudomonas aeruginosa on fomites

DOI: 10.1007/s40201-021-00770-2

Year: 2022

Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran

DOI: 10.3389/fped.2022.834306

Year: 2022

Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019

DOI: 10.1016/S0140-6736(21)02751-3

Year: 2022

Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019

DOI: 10.1016/S0140-6736(21)01546-4

Year: 2021

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1

DOI: 10.1016/S0140-6736(21)00984-3

Year: 2021

COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm

DOI: 10.1155/2021/8836403

Year: 2021

Comparing Watchful Waiting Approach vs. Antibiotic Therapy in Children with Nonsevere Acute Otitis Media: A Randomized Clinical Trial

DOI: 10.1155/2021/5515467

Year: 2021

Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019

DOI: 10.1016/S1473-3099(21)00449-7

Year: 2021

The Prospective Epidemiological Research Studies in IrAN (PERSIAN) Birth Cohort protocol: rationale, design and methodology

DOI: 10.1332/175795920x16062247639874

Year: 2021

Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial”

DOI: 10.1016/j.clinthera.2021.07.006

Year: 2021

How Do Hand Sanitizers Work?

What is the Future Outlook?

Why is Antibiotic Resistance a Global Health Concern?

How Do Extreme Weather Events Impact Infectious Disease Spread?

What are the Limitations of PCR Tests?

What Are the Common Concerns About Vaccines?

How is Lyme Disease Diagnosed?

How Does WHO Address Infectious Diseases?

How can public health initiatives promote condom use?

How is Gonorrhea Diagnosed?

Partnered Content Networks

Relevant Topics